D.A. Davidson Keeps Their Buy Rating on Diebold Nixdorf Inc (DBD)
TipRanks (Fri, 3-May 8:49 AM ET)
Diebold Nixdorf GAAP EPS of -$0.39, revenue of $897.1M
Seeking Alpha News (Thu, 2-May 7:12 AM ET)
Diebold Nixdorf Reports 2024 First Quarter Financial Results
PRNewswire (Thu, 2-May 7:00 AM ET)
EDEKA Jaeger Introduces AI-powered Age Verification at Self-Service Checkouts
PRNewswire (Tue, 30-Apr 8:04 AM ET)
Diebold Nixdorf Announces Thomas Timko as Chief Financial Officer
PRNewswire (Thu, 25-Apr 4:24 PM ET)
Diebold Nixdorf to Conduct 2024 First Quarter Investor Call on May 2
PRNewswire (Wed, 10-Apr 8:15 AM ET)
Diebold Nixdorf Reports 2023 Fourth Quarter and Full-Year Financial Results
PRNewswire (Wed, 14-Feb 7:00 AM ET)
Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are banking which offers integrated solutions for financial institutions and retail which offers solutions, software, and services which improve the checkout process for retailers.
Diebold Nixdorf trades on the NYSE stock market under the symbol DBD.
As of May 7, 2024, DBD stock price climbed to $39.93 with 376,327 million shares trading.
DBD has a beta of 0.75, meaning it tends to be less sensitive to market movements. DBD has a correlation of 0.06 to the broad based SPY ETF.
DBD has a market cap of $1.50 billion. This is considered a Small Cap stock.
Last quarter Diebold Nixdorf reported $895 million in Revenue and $1.19 earnings per share. This beat revenue expectation by $20 million and exceeded earnings estimates by $.96.
The top ETF exchange traded funds that DBD belongs to (by Net Assets): VTI, VXF, SCHA, FYX, DFAC.
DBD support price is $37.48 and resistance is $39.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DBD stock will trade within this expected range on the day.